NeoRecormon epoetin beta: Post-marketing study data

Data from the 3-year, open-label, international CREATE study in 603 patients with anemia related to chronic kidney

Read the full 174 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE